Evidence map›Paper›PMID 40719563›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

Modeling Reporting Delay in Cancer Incidence Counts in the Evolving US and Canadian Population-Based Cancer Registry Environment.

Huann-Sheng Chen, Douglas Midthune, Zhaohui Zou, Daniel Miller, Eric J Feuer

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Huann-Sheng ChenDivision of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, Maryland.ORCID 0000-0002-5905-8050
Douglas MidthuneDivision of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland.ORCID 0000-0002-3852-9407
Zhaohui ZouInformation Management Services, Inc., Calverton, Maryland.ORCID 0009-0003-2623-3531
Daniel MillerInformation Management Services, Inc., Calverton, Maryland.ORCID 0009-0007-0150-8374
Eric J FeuerDivision of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, Maryland.ORCID 0000-0003-4842-7751

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer incidence data collected by cancer registries in the United States and Canada are submitted to the North American Association of Central Cancer Registries, which publishes annual case counts for the two countries. To allow time to collect and report cases, counts for a given diagnosis year are initially published two years after the end of that year and updated annually. Initial counts typically underreport cases compared with updated counts due to reporting delays, potentially biasing estimated incidence trends.

methodsExisting methods for estimating "delay-adjusted" counts are modified for this heterogeneous group of registries exhibiting different patterns of reporting delay. The new method can be applied to individual registries and combined to produce delay-adjusted rates for the entire population, as well as for geographic or demographic subpopulations.

resultsSteps involved in estimating delay-adjusted counts are illustrated for liver and intrahepatic bile duct cancer in White males, in which delay-adjusted rates exhibit a stabilized trend, in contrast to the rapid decline seen in observed (unadjusted) rates. Additionally, the new delay model reveals reporting delays varying across cancer sites, race, and ethnicity. Finally, an extended model provides validated delay-adjusted rates from preliminary data that reduces reporting time from 2 years to 1 year.

conclusionsAdjusting for reporting delay provides more accurate estimates of cancer incidence trends. The proposed method addresses practical issues of model implementation and continues the evolution of delay adjustment in cancer registries. IMPACT: The new model extends the use of delay adjustment to an important source of cancer surveillance statistics.

Indexed as

NeoplasmsRegistriesCanadaFemaleHumansIncidenceMaleUnited States

Identifiers

PMID40719563
PMCPMC12491947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.